Correlation Between Oncolytics Biotech and RenovoRx

Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oncolytics Biotech and RenovoRx, you can compare the effects of market volatilities on Oncolytics Biotech and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and RenovoRx.

Diversification Opportunities for Oncolytics Biotech and RenovoRx

0.14

Correlation Coefficient

Oncolytics Biotech  RenovoRx

Average diversification

The 3 months correlation between Oncolytics and RenovoRx is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and RenovoRx go up and down completely randomly.

Pair Corralation between Oncolytics Biotech and RenovoRx

Given the investment horizon of 90 days Oncolytics Biotech is expected to under-perform the RenovoRx. But the stock apears to be less risky and, when comparing its historical volatility, Oncolytics Biotech is 1.22 times less risky than RenovoRx. The stock trades about -0.08 of its potential returns per unit of risk. The RenovoRx is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  127.00  in RenovoRx on November 28, 2024 and sell it today you would lose (30.00) from holding RenovoRx or give up 23.62% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Oncolytics Biotech  vs.  RenovoRx

Oncolytics Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Oncolytics Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

RenovoRx

Risk-Adjusted Performance

Very Weak

Over the last 90 days RenovoRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Oncolytics Biotech and RenovoRx

The main advantage of trading using opposite Oncolytics Biotech and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.

The idea behind Oncolytics Biotech and RenovoRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.